Redsense Medical has received a preemptive order from a US distribution partner as a proactive measure in anticipation of a pending potential tariff increase.

The order, originally scheduled for fulfillment in September, represents an estimated quarters worth of product with that distribution partner, and has been advanced to July as part of a strategic effort to mitigate potential cost impacts associated with upcoming trade changes. The company continues to monitor trade developments closely and remains committed to supporting its partners through flexible and responsive supply chain planning.

"This move demonstrates the strength of our partnerships and our ability to adapt quickly to market shifts. Together with other orders early in July this also already secures year on year growth early into the third quarter." says Sebastien Bollue, CEO of Redsense Medical AB.

Moreover the Clamp launch is on track with primary instruction translations made and first sample orders to distribution partners received. Distribution partners have started clinical demonstrations and discussions with providers, where the company has started a direct approach in Germany.